Glucose Deprivation Enhances the Antiproliferative Effects of Oral Hypoglycemic Biguanides in Different Molecular Subtypes of Breast Cancer: an in Vitro Study

1. K. M. De Bruijn, L. R. Arends, B. E. Hansen, S. Leeflang, R. Ruiter and C. H. van Eijck, Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer, Br. J. Surg. 100 (2013) 1421-1429; http://doi.org/10.1002/bjs.922910.1002/bjs.9229Search in Google Scholar

2. WHO, Global Status Report on Noncommunicable Diseases 2010, Description of the Global Burden of NCDs, Their Risk Factors and Determinants, World Health Organization, Geneva, Switzerland, 2011.Search in Google Scholar

3. Z. J. Zhang and S. Li, The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis, Diabetes Obes. Metab. 16 (2014) 707-710; http://doi.org/10.1111/dom.1226710.1111/dom.12267Search in Google Scholar

4. I. Wolf, S. Sadetzki, R. Catane, A. Karasik and B. Kaufman, Diabetes mellitus and breast cancer, Lancet Oncol. 6 (2005) 103-111; http://doi.org/10.1016/S1470-2045(05)01736-510.1016/S1470-2045(05)01736-5Search in Google Scholar

5. K. S. Peairs, B. B. Barone, C. F. Snyder, H. C. Yeh, K. B. Stein, R. L. Derr, F. L. Brancati and A. C. Wolff, Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis, J. Clin. Oncol. 29 (2011) 40-46; http://doi.org/10.1200/JCO.2009.27.301110.1200/JCO.2009.27.3011305585821115865Search in Google Scholar

6. D. Hanahan and R. A. Weinberg, Hallmarks of cancer: the next generation, Cell 144 (2011) 646-674; http://doi.org/10.1016/j.cell.2011.02.01310.1016/j.cell.2011.02.01321376230Search in Google Scholar

7. C. Catsburg, M. J. Gunter, C. Chen, M. L. Cote, G. C. Kabat, R. Nassir, L. Tinker, J. Wactawski- Wende, D. L. Page and T. E. Rohan, Insulin, estrogen, inflammatory markers, and risk of benign proliferative breast disease, Cancer Res. 74 (2014) 3248-3258; http://doi.org/10.1158/0008-5472.CAN-13-351410.1158/0008-5472.CAN-13-351424755474Search in Google Scholar

8. M. Jalving, J. A. Gietema, J. D. Lefrandt, S. de Jong, A. K. Reyners, R. O. Gans and E. G. de Vries, Metformin: taking away the candy for cancer?, Eur. J. Cancer 46 ( 2010) 2 369-2380; h ttp://doi.org/10.1016/j.ejca.2010.06.01210.1016/j.ejca.2010.06.01220656475Search in Google Scholar

9. J. H. Scarpello and H. C. Howlett, Metformin therapy and clinical uses, Diab. Vasc. Dis. Res. 5(2008) 157-167; http://doi.org/10.3132/dvdr.2008.02710.3132/dvdr.2008.02718777488Search in Google Scholar

10. W. C. Knowler, E. Barrett-Connor, S. E. Fowler, R. F. Hamman, J. M. Lachin, E. A. Walker and D. M. Nathan, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N. Engl. J. Med. 346 (2002) 393-403; http://doi.org/10.1056/NEJMoa01251210.1056/NEJMoa012512137092611832527Search in Google Scholar

11. Y. Zhuang and W. K. Miskimins, Cell cycle arrest in metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1, J. Mol. Signal.3 (2008) 18; http://doi.org/10.1186/1750-2187-3-1810.1186/1750-2187-3-18261339019046439Search in Google Scholar

12. M. Alalem, A. Ray and B. K. Ray, Metformin induces degradation of mTOR protein in breast cancer cells, Cancer Med. 5 (2016) 3194-3204; http://doi.org/10.1002/cam4.89610.1002/cam4.896511997527748082Search in Google Scholar

13. P. J. Goodwin, V. Stambolic, J. Lemieux, B. E. Chen, W. R. Parulekar, K. A. Gelmon, D. L. Hershman, T. J. Hobday, J. A. Ligibel, I. A. Mayer, K. I. Pritchard, T. J. Whelan, P. Rastogi and L. E. Shepherd, Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents, Breast Cancer Res. Treat. 126 (2011) 215-220; http://doi.org/10.1007/s10549-010-1224-110.1007/s10549-010-1224-120976543Search in Google Scholar

14. M. A. Khanfar, S. K. Bardaweel, M. R. Akl and K. A. El Sayed, Olive oil-derived oleocanthal as potent inhibitor of mammalian target of rapamycin: Biological evaluation and molecular modeling studies, Phytother. Res. 29 (2015) 1776-1782; http://doi.org/10.1002/ptr.543410.1002/ptr.5434505127326248874Search in Google Scholar

15. M. R. Owen, E. Doran and A. P. Halestrap, Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain, Biochem. J. 348 (2000)607-614.10.1042/bj3480607Search in Google Scholar